Drug Responses in Parkinson's Disease

Jo Knight worked on this project with Mario Masellis from Sunnybrook Hospital in Toronto and in partnership with the pharmaceutical company TEVA. Results from analysis of 692 participants of a drug trial showed that there was an association between response to the drug and genetic variant an individual would carry.